Health Care & Life Sciences » Pharmaceuticals » Biotechnology industry | Gilead Sciences top products by revenue 2013-2017

Gilead Sciences' top products based on revenue 2013-2017

Top products of Gilead Sciences from 2013 to 2017, based on revenue (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data displays the top products of biopharmaceutical company Gilead Sciences from 2011 to 2017, based on revenue. Gilead Sciences Inc. is headquartered in California and is specialized in discovering, developing and commercializing therapeutics. In 2011, Gilead Sciences' top product Atripla generated some 3.2 billion USD in revenue.

Harvoni 2127 13864 9081 4370
Genvoya 45 1484 3674
Truvada 3135.8 3340 3459 3566 3134
Atripla 3648.5 3470 3134 2605 1806
Stribild 539.3 1197 1825 1914 1053
Viread 959 1058 1108 1186 1046
Complera/Eviplera 809.5 1228 1427 1457 966
Sovaldi 139.4 10283 5276 4001 964
Letairis 520 595 700 819 887
Ranexa 448.6 510 588 677 717

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.